2011
Study
Name - Chronic Lymphocytic Leukemia
Study
Description -
To study the presence of human marginal zone (MZ) B cell markers in chronic lymphocytic leukemias carrying unmutated variable heavy chain antibody genes.
2010
Study
Name - NSABP B44 Beth
Study
Description -
NSABP B44 BETH - A Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with HER2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab CIRG (TRIO) 011/NSABP B44-1/B020906.
Study
Name - TAILOR X
Study
Description -
Program for the Assessment of Clinical Cancer Tests (PACCT-1) Trial Assigning IndividuaLized Options for Treatment (TAILORx)
Study
Name - NSABP FC4
Study
Description -
NSABP PROTOCOL FC-4/CP13-0708: A Randomized Phase II Clinical Trial Investigating Irinotecan Plus Cetuximab With or Without Anti-Insulin-Like Growth Factor-I Receptor Monoclonal Antibody (IMC-A12) for the Treatment of Patients with Metastatic K-RAS Wild-Type Carcinoma of the Colon or Rectum that has Progressed on Oxaliplatin and Bevacizumab Given as First-Line Therapy.
Study
Name - SWOG-S0421
Study
Description -
Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo For Patients with Advanced Hormone Refractory Prostate Cancer.
Study
Name - CoSoft
Study
Description -
Investigating cognitive function for patients participating in the
SOFT trial in selected centers
Study
Name - SOFT
Study
Description -
SOFT -
Suppression of Ovarian Function Trial, A Phase III CTSU Trial
Evaluating the Role of Ovarian Function Suppression and the
Role of Exemestane as Adjuvant Therapies for Premenopausal Women
with Endocrine Responsive Breast Cancer.
Study
Name - SWOG - S0307
Study
Description -
Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.
Study
Name - SWOG
9925 - Closed: 04/15/2010
Study
Description -
Lung cancer specimen repository protocol, ancillary
Study
Name - SWOG - S000B - Closed: 04/15/2010
Study
Description -
Prevention of Cataract and Age-Related Macular Degeneration with Vitamin E and Selenium - SELECT Eye Endpoints (SEE), Phase III Ancillary to S0000-SELECT.
Study
Name - NSABP
B-42 - Closed: 04/15/2010
Study
Description -
NSABP B-42 A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared to Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Free Survival in Postmenopausal Women with Hormone Receptor Positive Breast Cancer.
Study
Name - SWOG
S0226 - Closed: 01/15/2010
Study
Description -
Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First Line Therapy for Post Menopausal Women With Metastatic Breast Cancer
Study
Name - NSABP
LTS-01- Closed: 01/15/2010
Study
Description -
NSABP LTS-01
- Patient Reported Outcomes in Long Term Survivors with Colon
and Rectal Cancer.
2009
Study
Name - Avastin Aries - Closed: 11/16/2009
Study
Name - ECOG E5204 Closed: 5/13/2009
Study
Description -
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation.
Study
Name - NSABP
R-04 Closed: 5/13/2009
Study
Description -
A CLINICAL
TRIAL COMPARING PREOPERATIVE RADIATION THERAPY AND CAPECITABINE
WITH OR WITHOUT OXALIPLATIN WITH PREOPERATIVE RADIATION THERAPY
AND CONTINUOUS INTRAVENOUS INFUSION OF 5-FLUOROURACIL WITH OR
WITHOUT OXALIPLATIN IN THE TREATMENT OF PATIENTS WITH OPERABLE
CARCINOMA OF THE RECTUM
Study
Name - VELCADE Closed: 5/13/09
Study
Description -
VELCADE - i071-341-03 (IRRC #6016): Phase II Trial of Twice Weekly Induction Followed by Once Weekly IV VELCADE with Dexamethasone in Patients with Relapsed and/or Refractory Multiple Myeloma Following at Least One Prior Therapy.
Study
Name - NSABP
C-10 - Closed: 5/13/09
Study
Description -
A Phase
II Trial of 5-Fluorouracil, Leucovorin, and Oxaliplatin (mFOLFOX6)
Chemotherapy Plus Bevacizumab for Patients with Unresectable
Stage IV Colon Cancer and a Synchronous Asymptomatic Primary
Tumor.
Study
Name - VIRGO - Closed: 8/12/2009
AVF4349n
DNA REPOSITORY SUBSTUDY IN ASSOCIATION WITH STUDY AVF4349n
ARCHIVAL TISSUE COLLECTION SUBSTUDY IN ASSOCIATION WITH STUDY AVF4349N
Study
Description -
VIRGO - An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer AVF4349N; Archival Tissue Collection Substudy in Association with Study AV4349N; DNA Repository Substudy in Association with Study AVF4349N
2008
RTOG 0413
Closed: 11-12-2008
RTOG 0522
Closed: 11-12-2008
RTOG 0415
Closed: 11-12-2008
RTOG 0617/NCCTG
Closed: 11-12-2008
RTOG
0517
Closed: 11-12-2008
NSABP-B36
Closed: 08-13-2008
SWOG-S0500
Closed: 08-13-2008
SWOG-S0221
Closed: 08-13-2008
SWOG-S0600
Closed: 07-02-2008
NSABP PROTOCOL BP-59
Closed:
06-11-2008
NSABP PROTOCOL B-41
Closed:
06-11-2008
NSABP
B-40
Closed:
06-11-2008
NSABP
B-37
Closed:
06-11-2008
Co-STAR
Closed:
03-03-2008
RTOG
0435
Closed:
03-03-2008
ATLAS
Closed:
03-03-2008
SWOG-9346
Closed:
01-10-2008
2007
SWOG S00008
Closed:
12-2007
SWOG S0000B
Closed:
12-2007
RFS
2000
Closed:
10-2007
RTOG
0424
Closed:
09-2007
RTOG
0126
Closed:
09-2007
RTOG
0214
Closed:
09-2007
NSABP
B-38
Closed:
05-2007
RTOG
S0412
Closed:
01-2007
SWOG
S0124
Closed:
01-2007
SWOG
S0438
Closed:
01-20-07
|